Halozyme Therapeutics Inc... (HALO)
61.89
-1.92 (-3.01%)
At close: Apr 01, 2025, 3:39 PM
13F Institute Ownership
Total Institutes of 516 in Halozyme Therapeutics reduced their positions with a decrease of 2 investors compared to the previous quarter. A reduction of 1.75M shares, as total invested capital declined by $1.25B with ownership percentage dropping from 98.85% to 97.47%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.388
0.39
Call Flow 667,903
72%
Put Flow 259,300
28%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Blackrock, Inc. | 13.85% | 17.57M | +0.78% | 839.84M | 0.02% |
| Vanguard Group Inc | 10.47% | 13.28M | +3.00% | 635M | 0.01% |
| Snyder Capital Management L P | 3.29% | 4.17M | +2.59% | 199.29M | 4.17% |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.